Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Kevin Wood, MD, Sergio A Giralt, MD, Guenther Koehne, MD, PhD, David Chung, MD PhD, Nikoletta Lendvai, MD PhD, Hani Hassoun, MD, Alex Lesokhin, MD, Elizabeth Hoover, Sean Devlin, PhD, Heather Landau, MD

Blood (2012) 120 (21): 4550.

https://doi.org/10.1182/blood.V120.21.4550.4550

Published: 2012

Journal Articles

Reactive Polyclonal Gammopathy Associated with Polyclonal Plasmacytosis Is Common in Patients with Multiple Myeloma Receiving Prolonged Lenalidomide Therapy: A Retrospective Study of 104 Patients

Dmitriy Zamarin, MD PhD, Sean Devlin, PhD, Maria Arcila, MD, Sergio A. Giralt, MD, Heather Landau, MD, Alex Lesokhin, MD, Nikoletta Lendvai, MD PhD, David Chung, MD PhD, Danielle Chimento, BA, Dilip Babu, MD, Hani Hassoun, MD

Blood (2012) 120 (21): 4033.

https://doi.org/10.1182/blood.V120.21.4033.4033

Published: 2012

Journal Articles

Phase II Study of Infusional Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma

Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alexander Lesokhin, MD, Ioanna Tsakos, BS, Guenther Koehne, MD, PhD, David Chung, MD PhD, Sean Devlin, PhD, Hani Hassoun, MD, Sergio A Giralt, MD

Blood (2012) 120 (21): 947.

https://doi.org/10.1182/blood.V120.21.947.947

Published: 2012

Journal Articles

Polyclonal IgA Gammopathy Associated with Polyclonal Plasmacytosis in Patients Receiving Lenalidomide Maintenance Therapy

Dmitriy Zamarin, MD PhD, Maria Arcila, MD, Sergio A Giralt, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alex Lesokhin, MD, David Chung, MD PhD, Danielle Chimento, BA, Hani Hassoun, MD

Blood (2011) 118 (21): 5130.

https://doi.org/10.1182/blood.V118.21.5130.5130

Published: 2011

Journal Articles

Patterns of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line Therapy with Autologous Stem Cell Transplantation: Implications for Patient Monitoring After Transplantation

Dmitriy Zamarin, MD PhD, Manisha Bhutani, MD, Danielle Chimento, BA, Sergio Giralt, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Alex Lesokhin, MD, David Chung, MD PhD, Dilip Babu, MD, Hani Hassoun, MD

Blood (2011) 118 (21): 825.

https://doi.org/10.1182/blood.V118.21.825.825

Published: 2011

Journal Articles

Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma

Daniel E Fein, Hani Hassoun, MD, Raymond L. Comenzo, MD, Alex Lesokhin, Nikoletta Lendvai, MD, PhD, David Chung, MD, PhD, Adam Cohen, Michael A. Rosenzweig, MD, Danielle Chimento, Xiaoyu Jia, Stephen Nimer, Sergio Giralt, MD, Heather Landau, MD

Blood (2010) 116 (21): 1353.

https://doi.org/10.1182/blood.V116.21.1353.1353

Published: 2010

NARROW

Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Reactive Polyclonal Gammopathy Associated with Polyclonal Plasmacytosis Is Common in Patients with Multiple Myeloma Receiving Prolonged Lenalidomide Therapy: A Retrospective Study of 104 Patients

Phase II Study of Infusional Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma

Polyclonal IgA Gammopathy Associated with Polyclonal Plasmacytosis in Patients Receiving Lenalidomide Maintenance Therapy

Patterns of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line Therapy with Autologous Stem Cell Transplantation: Implications for Patient Monitoring After Transplantation

Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Reactive Polyclonal Gammopathy Associated with Polyclonal Plasmacytosis Is Common in Patients with Multiple Myeloma Receiving Prolonged Lenalidomide Therapy: A Retrospective Study of 104 Patients

Phase II Study of Infusional Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma

Polyclonal IgA Gammopathy Associated with Polyclonal Plasmacytosis in Patients Receiving Lenalidomide Maintenance Therapy

Patterns of Disease Relapse and Progression in Patients with Multiple Myeloma After First Line Therapy with Autologous Stem Cell Transplantation: Implications for Patient Monitoring After Transplantation

Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only